<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="lrrk2" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">lrrk2</book-part-id>
      <title-group>
        <title><italic toggle="yes">LRRK2</italic>-Related Parkinson Disease</title>
        <alt-title alt-title-type="alt-title">Synonyms: <italic toggle="yes">LRRK2</italic>-Associated Parkinson Disease, PARK8</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Trinh</surname>
            <given-names>Joanne</given-names>
          </name>
          <xref ref-type="aff" rid="lrrk2.AFF1"/>
          <degrees>BSc</degrees>
          <email>jtrinh@can.ubc.ca</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Farrer</surname>
            <given-names>Matthew</given-names>
          </name>
          <xref ref-type="aff" rid="lrrk2.AFF2"/>
          <degrees>PhD</degrees>
          <email>mfarrer@can.ubc.ca</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Ross</surname>
            <given-names>Owen A</given-names>
          </name>
          <xref ref-type="aff" rid="lrrk2.AFF3"/>
          <degrees>PhD</degrees>
          <email>ross.owen@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Guella</surname>
            <given-names>Ilaria</given-names>
          </name>
          <xref ref-type="aff" rid="lrrk2.AFF4"/>
          <degrees>PhD</degrees>
          <email>iguella@can.ubc.ca</email>
        </contrib>
      </contrib-group>
      <aff id="lrrk2.AFF1">Center of Applied Neurogenetics<break/>University of British Columbia<break/>Vancouver, British Columbia</aff>
      <aff id="lrrk2.AFF2">Center of Applied Neurogenetics<break/>University of British Columbia<break/>Vancouver, British Columbia </aff>
      <aff id="lrrk2.AFF3">Department of Neuroscience<break/>Mayo Clinic<break/>Jacksonville, Florida </aff>
      <aff id="lrrk2.AFF4">Center of Applied Neurogenetics<break/>University of British Columbia<break/>Vancouver, British Columbia</aff>
      <pub-history>
        <date iso-8601-date="2006-11-02" date-type="created">
          <day>02</day>
          <month>11</month>
          <year>2006</year>
        </date>
        <date iso-8601-date="2014-12-11" date-type="updated">
          <day>11</day>
          <month>12</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="dcm-lmna" document-type="chapter">
<italic toggle="yes">LMNA</italic>-Related Dilated Cardiomyopathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="ltbp4-cutis-laxa" document-type="chapter">
<italic toggle="yes">LTBP4</italic>-Related Cutis Laxa</related-object>
      <abstract id="lrrk2.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">LRRK2</italic>-related Parkinson disease (PD) is characterized by features consistent with idiopathic PD: initial motor features of slowly progressive asymmetric tremor at rest and/or bradykinesia, cog-wheel muscle rigidity, postural instability, and gait abnormalities that may include festination and freezing. Non-motor symptoms in <italic toggle="yes">LRRK2</italic>-related PD occur with similar frequency as observed in typical idiopathic PD. Onset is generally after age 50 years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">LRRK2</italic>-related PD relies on clinical findings and the identification of a pathogenic variant in <italic toggle="yes">LRRK2</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Pharmacologic replacement of dopamine, most commonly accomplished with the precursor of dopamine, L-dopa, combined with carbi-dopa. Dopamine agonists may also be used, as well as inhibitors of catechol-O-methyltransferase (COMT) or monoamine oxidase-B (MAO-B). Physical, occupational, and speech therapy may help. Neurosurgical procedures, such as deep brain stimulation of the subthalamic nucleus/globus pallidus interna or pallido-pontine nucleus, benefit some individuals in whom dyskinesias or gait disorders are especially problematic. Less commonly pallidotomy, or rarely fetal brain transplant to the caudate nucleus, may also provide benefit. </p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Prevention of L-dopa induced dyskinesias may include deep-brain stimulation, constant drug delivery/stimulation (CDD/CDS), reduction of levodopa doses, and the use of dopamine receptor agonists.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual neurologic examination to assess gait, tremor, rigidity, cognition and mood. </p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Neuroleptic treatment may exacerbate parkinsonism.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">LRRK2</italic>-related PD is inherited in an autosomal dominant manner. However, given the reduced penetrance associated with <italic toggle="yes">LRRK2</italic>-related PD, a high percentage of affected individuals report unaffected parents. <italic toggle="yes">De novo</italic> mutation may occur; its frequency is unknown. Each child of an individual with <italic toggle="yes">LRRK2</italic>-related Parkinson disease has a 50% chance of inheriting the pathogenic variant. However, the risk of developing disease is lower than 50% because of age-related penetrance. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="lrrk2.Diagnosis">
        <title>Diagnosis</title>
        <sec id="lrrk2.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">LRRK2</italic>-related Parkinson disease (PD) relies on clinical findings and the identification of a pathogenic variant in <italic toggle="yes">LRRK2</italic>.</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Motor features of <italic toggle="yes">LRRK2</italic>-related PD are generally indistinguishable from those of idiopathic PD and include the following [<xref ref-type="bibr" rid="lrrk2.REF.aasly.2005.762">Aasly et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gosal.2005.349">Gosal et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ishihara.2006.1250">Ishihara et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.alcalay.2013.1966">Alcalay et al 2013</xref>, <xref ref-type="bibr" rid="lrrk2.REF.trinh.2014b.1">Trinh et al 2014b</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Asymmetric tremor at rest</p>
                </list-item>
                <list-item>
                  <p>Bradykinesia</p>
                </list-item>
                <list-item>
                  <p>Muscle rigidity</p>
                </list-item>
                <list-item>
                  <p>Postural instability</p>
                </list-item>
                <list-item>
                  <p>Gait abnormalities including festination and freezing</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Onset is typically after age 50 years.</p>
            </list-item>
            <list-item>
              <p>Disease course is slowly progressive.</p>
            </list-item>
            <list-item>
              <p>Response to low to moderate doses of levodopa is generally good.</p>
            </list-item>
            <list-item>
              <p>Postural instability and gait difficulty may be more likely in individuals with a pathogenic variant in <italic toggle="yes">LRRK2</italic> than in those with idiopathic PD [<xref ref-type="bibr" rid="lrrk2.REF.alcalay.2013.1966">Alcalay et al 2013</xref>, <xref ref-type="bibr" rid="lrrk2.REF.mirelman.2013.1683">Mirelman et al 2013</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="lrrk2.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">LRRK2</italic>, encoding leucine-rich repeat serine/threonine-protein kinase 2, is the only gene in which pathogenic variants are known to cause <italic toggle="yes">LRRK2</italic>-related PD. </p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="lrrk2.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">LRRK2</italic>-Related Parkinson Disease</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
                <tr>
                  <td headers="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_1" align="left" valign="middle" rowspan="3" colspan="1">
                    <italic toggle="yes">LRRK2</italic>
                  </td>
                  <td headers="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Targeted mutation analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Varies by ethnicity</td>
                </tr>
                <tr>
                  <td headers="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td>
                  <td headers="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">~100%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6,&#x000a0;7</sup></td>
                  <td headers="hd_b_lrrk2.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="lrrk2.TF.1">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="lrrk2" object-id="lrrk2.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="lrrk2.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene. </p>
              </fn>
              <fn id="lrrk2.TF.1.1">
                <label>2.</label>
                <p>Testing panel may vary by laboratory. Some panels may include less penetrant pathogenic variants (twofold risk) specific to Asian communities, including <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1628Pro</xref> and <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2385Arg</xref> which are also seen in &#x0003e;1% of the healthy population. At least seven variants are known to be pathogenic (see <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">Table 3</xref>, <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="PDF File" xlink:href="lrrk2-tables4-5.pdf" content-type="local-data">Tables 4-5</inline-supplementary-material> [pdf]) [<xref ref-type="bibr" rid="lrrk2.REF.paisanruiz.2004.595">Paisan-Ruiz et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.zimprich.2004.601">Zimprich et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.difonzo.2005.412">Di Fonzo et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gilks.2005.415">Gilks et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.kachergus.2005.672">Kachergus et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.nichols.2005.410">Nichols et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.difonzo.2006b.133">Di Fonzo et al 2006b</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ross.2008.88">Ross et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.aasly.2010.2156">Aasly et al 2010</xref>]. Mutation detection rates vary by ethnicity.</p>
              </fn>
              <fn id="lrrk2.TF.1.2">
                <label>3.</label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="lrrk2.TF.1.3">
                <label>4.</label>
                <p>Other <italic toggle="yes">LRRK2</italic> substitutions including p.Arg1441His, p.Ala1442Pro, and p.Ile2012Thr are likely to be pathogenic. <italic toggle="yes">LRRK2</italic> p.Asn1437His, albeit rare, is another likely pathogenic mutation. Two risk factors (<xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1628Pro</xref> and <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2385Arg</xref>) have been confirmed in Asian populations [<xref ref-type="bibr" rid="lrrk2.REF.difonzo.2006b.133">Di Fonzo et al 2006b</xref>, <xref ref-type="bibr" rid="lrrk2.REF.tan.2006.857">Tan et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.tomiyama.2006.1102">Tomiyama et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.farrer.2007.89">Farrer et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.lu.2008.271">Lu et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ross.2008.88">Ross et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.tan.2008.287">Tan et al 2008</xref>]. At least 250 other coding variants have been observed, with at least 80 leading to nonsynonymous amino acid substitutions. The most frequent <italic toggle="yes">LRRK2</italic> exonic variants have been described in worldwide case-control series, and many have been assigned as contributing to risk or protection from Parkinson disease [<xref ref-type="bibr" rid="lrrk2.REF.ross.2011.898">Ross et al 2011</xref>]. </p>
              </fn>
              <fn id="lrrk2.TF.1.4">
                <label>5.</label>
                <p><italic toggle="yes">LRRK2</italic>-related PD is defined by the presence of a pathogenic variant in <italic toggle="yes">LRRK2</italic>; thus the mutation detection rate approaches 100% for nucleotide changes, small deletions/insertions, and mutations in splice site consensus motifs. </p>
              </fn>
              <fn id="lrrk2.TF.1.5">
                <label>6.</label>
                <p>Testing that identifies exonic or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="lrrk2.TF.1.6">
                <label>7.</label>
                <p>To date, no deletions or duplications involving <italic toggle="yes">LRRK2</italic> have been reported to cause <italic toggle="yes">LRRK2</italic>-related Parkinson disease [<xref ref-type="bibr" rid="lrrk2.REF.mata.2005a.171">Mata et al 2005a</xref>, <xref ref-type="bibr" rid="lrrk2.REF.difonzo.2006a.322">Di Fonzo et al 2006a</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="lrrk2.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> A diagnosis of <italic toggle="yes">LRRK2</italic>-related Parkinson disease is confirmed when an individual has one of the known <italic toggle="yes">LRRK2</italic> pathogenic variants.</p>
          <p><bold>One genetic testing strategy</bold> is molecular genetic testing of <italic toggle="yes">LRRK2</italic> only. </p>
          <list list-type="bullet">
            <list-item>
              <p>Given the population-specific nature of <italic toggle="yes">LRRK2</italic> variants and the large number of exons that need to be sequenced, it may be cost-effective to begin with targeted mutation analysis based on ethnicity:</p>
              <list list-type="bullet">
                <list-item>
                  <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1441Gly</xref> appears to be restricted to those with Spanish or Hispanic ancestors.</p>
                </list-item>
                <list-item>
                  <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2019Ser</xref> should be tested first in those of Jewish or North African Berber ancestry.</p>
                </list-item>
                <list-item>
                  <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1441Cys</xref> is most frequent in those with Belgian ancestry.</p>
                </list-item>
                <list-item>
                  <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1628Pro</xref> and <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2385Arg</xref> are only prevalent in individuals of Asian ancestry.</p>
                </list-item>
                <list-item>
                  <p>Other, rarer <italic toggle="yes">LRRK2</italic> variants appear to have more global distribution.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If targeted mutation analysis does not identify the ethnic-specific pathogenic variant or if ethnicity is unknown, sequence analysis of the entire coding region should be performed starting with exons encoding the Roc, COR and kinase domains.</p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">LRRK2</italic> and other genes of interest (see <xref ref-type="sec" rid="lrrk2.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
        </sec>
      </sec>
      <sec id="lrrk2.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="lrrk2.Natural_History">
          <title>Clinical Description</title>
          <p><italic toggle="yes">LRRK2</italic>-related Parkinson disease (PD) is characterized by features consistent with idiopathic PD: initial motor features of asymmetric tremor at rest and/or bradykinesia, cog-wheel muscle rigidity, postural instability, and gait abnormalities including festination and freezing.</p>
          <p>Onset is insidious and the disease course is slowly progressive. Age at onset is variable, even within a family. The mean age at onset is approximately 60 years, typical of late-onset Parkinson disease. The reported range in age of onset is 28 to 82 years [<xref ref-type="bibr" rid="lrrk2.REF.ishihara.2006.1250">Ishihara et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.kay.2006.519">Kay et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.trinh.2014b.1">Trinh et al 2014b</xref>]. Men and women are affected equally.</p>
          <p>Non-motor symptoms in <italic toggle="yes">LRRK2</italic>-related PD, seen as frequently as in typical idiopathic PD, may include constipation, seborrhea, hyposmia/anosmia, sympathetic denervation of the heart, disorders of mood (apathy, depression), cognitive decline, dementia, and sleep disorders. They may appear prior to the movement disorder or emerge with motor disease progression. Constipation, mood disorders, olfactory dysfunction and sleep disorders are potential preclinical markers of PD. Virtually all individuals with PD demonstrate some sleep disruption, from excessive daytime sleepiness to REM-sleep behavior disorder, which may manifest very early in the disease course. Mild cognitive impairment and dementia may occur later in the disease. Depression is quite common and can occur in up to 40% of affected individuals [<xref ref-type="bibr" rid="lrrk2.REF.chaudhuri.2006.235">Chaudhuri et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.langston.2006.591">Langston 2006</xref>]. </p>
          <p>Most studies have shown comparable clinical features between individuals with <italic toggle="yes">LRRK2</italic>-related PD and idiopathic PD [<xref ref-type="bibr" rid="lrrk2.REF.alcalay.2013.1966">Alcalay et al 2013</xref>]. However, REM sleep behavior disorder and gastrointestinal dysfunction have been reported to be less severe in a large cohort of individuals of Tunisian Arab-Berber descent with the <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2019Ser</xref> pathogenic variant in <italic toggle="yes">LRRK2</italic> compared to those with idiopathic PD [<xref ref-type="bibr" rid="lrrk2.REF.trinh.2014a.1125">Trinh et al 2014a</xref>]. </p>
          <p>Seven members of one family (the 'Lincolnshire kindred,' in which the pathogenic variant <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Tyr1699Cys</xref> segregates) presented with a behavioral disorder characterized by depression and anxiety [<xref ref-type="bibr" rid="lrrk2.REF.khan.2005.2786">Khan et al 2005</xref>]. The initial family identified with the p.Tyr1699Cys pathogenic variant ('Family A') [<xref ref-type="bibr" rid="lrrk2.REF.zimprich.2004.601">Zimprich et al 2004</xref>] also presented with atypical symptoms of dementia and amyotrophy.</p>
          <p>Cognitive impairment does not appear to be more common in <italic toggle="yes">LRRK2</italic>-related PD than in typical sporadic disease; however, one report of individuals with the <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2019Ser</xref> pathogenic variant suggested that Mini-Mental State Examination scores were lower than expected [<xref ref-type="bibr" rid="lrrk2.REF.lesage.2005.784">Lesage et al 2005</xref>]. These findings, however, do not reflect the vast majority of individuals with <italic toggle="yes">LRRK2</italic>-related PD and further clinical studies suggest that cognitive impairment may occur less frequently in individuals heterozygous for the p.Gly2019Ser variant [<xref ref-type="bibr" rid="lrrk2.REF.healy.2008.583">Healy et al 2008</xref>]. Subsequent studies showed that those with <italic toggle="yes">LRRK2</italic>-related PD have cognitive impairment comparable to that associated with idiopathic PD [<xref ref-type="bibr" rid="lrrk2.REF.alcalay.2013.1966">Alcalay et al 2013</xref>, <xref ref-type="bibr" rid="lrrk2.REF.estanga.2014.1097">Estanga et al 2014</xref>]. </p>
          <p>
            <bold>Neuroimaging</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Brain CT and MRI are normal.</p>
            </list-item>
            <list-item>
              <p>Positron emission tomography (PET) associated with the <italic toggle="yes">LRRK2</italic> pathogenic variants p.Gly2019Ser, p.Tyr1699Cys, and <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1441Cys</xref> shows significant reduction in <sup>18</sup>F-dopa uptake compared to controls; as is typical of late-onset PD, the reduced uptake is asymmetric with a rostrocaudal gradient and the putamen more affected than the caudate [<xref ref-type="bibr" rid="lrrk2.REF.adams.2005.2777">Adams et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.hernandez.2005.453">Hernandez et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.khan.2005.2786">Khan et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.paisanruiz.2005.365">Paisan-Ruiz et al 2005</xref>]. Comparable reduction in uptake may also be observed for the presynaptic membrane dopamine transporter (<italic toggle="yes">SLCA3</italic>) and vesicular monoamine transporter (<italic toggle="yes">SLC18A2</italic>) [<xref ref-type="bibr" rid="lrrk2.REF.adams.2005.2777">Adams et al 2005</xref>]. Similar findings may be seen in asymptomatic individuals with one of the same <italic toggle="yes">LRRK2</italic> pathogenic variants [<xref ref-type="bibr" rid="lrrk2.REF.adams.2005.2777">Adams et al 2005</xref>]. In a recent study of a <italic toggle="yes">LRRK2</italic> kindred with the p.Arg1441Cys pathogenic variant, PET studies with a variety of pre- and postsynaptic tracers revealed progressive dopaminergic dysfunction in motor-impaired affected individuals as well as young asymptomatic heterozygotes [<xref ref-type="bibr" rid="lrrk2.REF.nandhagopal.2008.1790">Nandhagopal et al 2008</xref>].</p>
            </list-item>
          </list>
          <p><bold>Neuropathology.</bold> The hallmark pathologic features of the common idiopathic form of PD are neuronal loss and gliosis in the substantia nigra and the presence of intracytoplasmic inclusions (or Lewy bodies). The majority of individuals with <italic toggle="yes">LRRK2</italic>-related PD exhibit these characteristics [<xref ref-type="bibr" rid="lrrk2.REF.ross.2006.388">Ross et al 2006</xref>]. However, <italic toggle="yes">LRRK2</italic>-related PD has also been documented with four alternate pathologies including the following [<xref ref-type="bibr" rid="lrrk2.REF.wszolek.2004.1619">Wszolek et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.zimprich.2004.601">Zimprich et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.funayama.2005.918">Funayama et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ross.2006.388">Ross et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.covy.2009.32">Covy et al 2009</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ujiie.2012.819">Ujiie et al 2012</xref>]: </p>
          <list list-type="bullet">
            <list-item>
              <p>Nigral neuronal loss and gliosis without Lewy body inclusions</p>
            </list-item>
            <list-item>
              <p>Neurofibrillary tangles</p>
            </list-item>
            <list-item>
              <p>Ubiquitin-immunopositive inclusions (Marinesco bodies)</p>
            </list-item>
            <list-item>
              <p>TDP-43 inclusions </p>
            </list-item>
          </list>
          <p>Immunostaining for Lrrk2 protein has also been reported within inclusion bodies including Lewy pathology, although the specificity of the antibodies used for immunohistochemistry has not been confirmed [<xref ref-type="bibr" rid="lrrk2.REF.giasson.2006.315">Giasson et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.miklossy.2006.953">Miklossy et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.biskup.2007.102">Biskup et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.higashi.2007.208">Higashi et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.alegreabarrategui.2008.272">Alegre-Abarrategui et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.perry.2008.222">Perry et al 2008</xref>].</p>
          <p><italic toggle="yes">LRRK2</italic>-related PD has the potential to be the 'Rosetta stone' of parkinsonian disorders because: (1) all the major pathologies associated with parkinsonism have been observed; and (2) the end-stage pathology may differ even in families with the same pathogenic variant (see <xref ref-type="table" rid="lrrk2.T.number_of_individuals_with_lrrk2">Table 2</xref>). For example:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants"><bold>p.Arg1441Cys</bold></xref>. Four members of Family D with this pathogenic variant had variable, pleomorphic pathology: </p>
              <list list-type="bullet">
                <list-item>
                  <p>One with diffuse Lewy body disease within the cortex and brain stem; </p>
                </list-item>
                <list-item>
                  <p>One with Lewy bodies restricted to brain stem, typical of idiopathic PD; </p>
                </list-item>
                <list-item>
                  <p>One with a 4R-tauopathy with globose neurofibrillary tangles and tufted astrocytes, reminiscent of argyrophilic grains disease and progressive supranuclear palsy (PSP); and </p>
                </list-item>
                <list-item>
                  <p>One with nigral neuronal degeneration and gliosis, without coexisting pathology [<xref ref-type="bibr" rid="lrrk2.REF.wszolek.2004.1619">Wszolek et al 2004</xref>]. </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants"><bold>p.Tyr1699Cys</bold></xref>. Two members of Family A with this pathogenic variant had ubiquitin-immunoreactive cytoplasmic and nuclear inclusions (Marinesco bodies), and a third had brain stem Lewy body disease [<xref ref-type="bibr" rid="lrrk2.REF.zimprich.2004.601">Zimprich et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants"><bold>p.Gly2019Ser</bold></xref>. As the most common pathogenic variant, p.Gly2019Ser is present in the majority of autopsied cases, in which brain stem or transitional, &#x003b1;-synuclein immunopositive Lewy body pathology is observed [<xref ref-type="bibr" rid="lrrk2.REF.taylor.2006.76">Taylor et al 2006</xref>]. Rarely, however, nigral neuronal loss and gliosis only or alternate tauopathy or ubiquitin-immunopositive pathology are observed [<xref ref-type="bibr" rid="lrrk2.REF.giasson.2006.315">Giasson et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ross.2006.388">Ross et al 2006</xref>] (see <xref ref-type="table" rid="lrrk2.T.number_of_individuals_with_lrrk2">Table 2</xref>).</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants"><bold>p.Ile2020Thr</bold></xref>. In four members of the Sagamihara kindred with this pathogenic variant only moderate nigral neuronal degeneration and gliosis with no coexisting intracytoplasmic lesion pathology were observed [<xref ref-type="bibr" rid="lrrk2.REF.funayama.2005.918">Funayama et al 2005</xref>]. Tau pathology has since been present in six individuals with this pathogenic variant [<xref ref-type="bibr" rid="lrrk2.REF.ujiie.2012.819">Ujiie et al 2012</xref>]. </p>
            </list-item>
          </list>
          <table-wrap id="lrrk2.T.number_of_individuals_with_lrrk2" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p>Number of Individuals with <italic toggle="yes">LRRK2</italic>-Related PD with Distinct Pathogenic Findings</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">LRRK2</italic> Pathogenic Variant</th>
                  <th id="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Lewy Bodies and Neurites</th>
                  <th id="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Tau and NFTs</th>
                  <th id="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Ubiquitin</th>
                  <th id="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">Neuronal Loss Only</th>
                </tr>
                <tr>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">p.Arg1441Cys</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">2</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">p.Tyr1699Cys</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">p.Gly2019Ser</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">13</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">2</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">p.Ile2020Thr</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">1</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">6</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_lrrk2.T.number_of_individuals_with_lrrk2_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">6</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="lrrk2.TF.2">
                <p>NFTs=neurofibrillary tangles</p>
              </fn>
              <fn id="lrrk2.TF.2.1">
                <p><xref ref-type="bibr" rid="lrrk2.REF.zimprich.2004.601">Zimprich et al [2004]</xref>, <xref ref-type="bibr" rid="lrrk2.REF.funayama.2005.918">Funayama et al [2005]</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gilks.2005.415">Gilks et al [2005]</xref>, <xref ref-type="bibr" rid="lrrk2.REF.giasson.2006.315">Giasson et al [2006]</xref>, <xref ref-type="bibr" rid="lrrk2.REF.rajput.2006.1506">Rajput et al [2006]</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ross.2006.388">Ross et al [2006]</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ujiie.2012.819">Ujiie et al [2012]</xref></p>
              </fn>
              <fn id="lrrk2.TF.2.2">
                <p>In some cases with neuronal loss and otherwise nonspecific findings, TDP-43 immunopositive inclusions may be observed [<xref ref-type="bibr" rid="lrrk2.REF.covy.2009.32">Covy et al 2009</xref>; Dennis Dickson, personal communication].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="lrrk2.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Although previously no certain correlations between specific <italic toggle="yes">LRRK2</italic> pathogenic variants and age at onset, clinical presentation, or disease progression had been found [<xref ref-type="bibr" rid="lrrk2.REF.haugarvoll.2008.1456">Haugarvoll et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.healy.2008.583">Healy et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.hulihan.2008.591">Hulihan et al 2008</xref>], larger cohorts have shown that in Ashkenazi Jewish populations, individuals heterozygous for the <italic toggle="yes">LRRK2</italic>
<xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2019Ser</xref> pathogenic variant are more likely to have postural instability and gait disorders [<xref ref-type="bibr" rid="lrrk2.REF.alcalay.2013.1966">Alcalay et al 2013</xref>]. Furthermore, disease progression in p.Gly2019Ser heterozygotes appears to be uniform regardless of age at onset [<xref ref-type="bibr" rid="lrrk2.REF.trinh.2014b.1">Trinh et al 2014b</xref>]. Neuropathologic correlations are noted in <xref ref-type="table" rid="lrrk2.T.number_of_individuals_with_lrrk2">Table 2</xref>.</p>
          <p>'Dardarin,' the Basque word for tremor, was initially proposed as a name for the protein encoded by <italic toggle="yes">LRRK2</italic>, leucine-rich repeat serine/threonine-protein kinase 2 (Lrrk2) to highlight excessive tremor in families from this region with the <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1441Gly</xref> pathogenic variant; however, individuals with this pathogenic variant may also present with bradykinesia [<xref ref-type="bibr" rid="lrrk2.REF.paisanruiz.2004.595">Paisan-Ruiz et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.mata.2005b.309">Mata et al 2005b</xref>].</p>
        </sec>
        <sec id="lrrk2.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance of <italic toggle="yes">LRRK2</italic> pathogenic variants is age dependent but may vary depending on pathogenic variant and population ethnicity. </p>
          <p>In population-based studies, <xref ref-type="bibr" rid="lrrk2.REF.ozelius.2006.424">Ozelius et al [2006]</xref> determined the lifetime penetrance of <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Gly2019Ser</xref> parkinsonism by two methods: </p>
          <list list-type="bullet">
            <list-item>
              <p>Comparing the frequency of individuals with the p.Gly2019Ser pathogenic variant among individuals with PD vs. unrelated controls (penetrance: 35.2%); AND</p>
            </list-item>
            <list-item>
              <p>Calculating the proportion of the parents of these individuals diagnosed with PD (penetrance: 31.8%). This estimate is similar to that provided by <xref ref-type="bibr" rid="lrrk2.REF.goldwurm.2007.1141">Goldwurm et al [2007]</xref>. </p>
            </list-item>
          </list>
          <p>The lifetime penetrance in the Tunisian Arab-Berber population in which p.Gly2019Ser is most frequent is 45% [<xref ref-type="bibr" rid="lrrk2.REF.hulihan.2008.591">Hulihan et al 2008</xref>]. However, as penetrance is a function of age, it may be more meaningfully defined as an age-associated cumulative risk. In an Arab-Berber sample with the p.Gly2019Ser pathogenic variant, the symptoms of parkinsonism manifest in fewer than 20% of heterozygotes younger than age 50 years but in more than 80% of those age 70 years and older. In this population the odds ratio of disease in those heterozygous for the p.Gly2019Ser variant is 22.6 (95% CI 10.2-50.1) [<xref ref-type="bibr" rid="lrrk2.REF.hulihan.2008.591">Hulihan et al 2008</xref>]. The risk to heterozygotes and rarer homozygotes is equivalent [<xref ref-type="bibr" rid="lrrk2.REF.ishihara.2006.1250">Ishihara et al 2006</xref>].</p>
          <p>In contrast, analysis of multiplex families (i.e., families with &#x0003e;1 affected individual) identified a higher lifetime penetrance estimate of around 67% compared to the estimate for simplex cases [<xref ref-type="bibr" rid="lrrk2.REF.kachergus.2005.672">Kachergus et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.healy.2008.583">Healy et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.latourelle.2008.32">Latourelle et al 2008</xref>]. The initial study for <italic toggle="yes">LRRK2</italic> p.Gly2019Ser suggests that the probability of a heterozygote manifesting symptoms is lower than 20% at age 50 years and increases in an almost linear fashion to more than 80% at age 75 years [<xref ref-type="bibr" rid="lrrk2.REF.kachergus.2005.672">Kachergus et al 2005</xref>]. The most recent study suggests that the risk of manifesting disease is about 8% at age 50 years but greater than 55% at 75 years [<xref ref-type="bibr" rid="lrrk2.REF.latourelle.2008.32">Latourelle et al 2008</xref>]. However, asymptomatic p.Gly2019Ser heterozygotes older than age 80 years have been reported [<xref ref-type="bibr" rid="lrrk2.REF.kay.2005.1077">Kay et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.carminebelin.2006.1731">Carmine Belin et al 2006</xref>]. </p>
          <p>More recently, gender has been shown to influence the cumulative incidence of symptom development in individuals heterozygous for a <italic toggle="yes">LRRK2</italic> pathogenic variant, with females becoming affected a median of five years earlier than males [<xref ref-type="bibr" rid="lrrk2.REF.cilia.2014.911">Cilia et al 2014</xref>, <xref ref-type="bibr" rid="lrrk2.REF.trinh.2014a.1125">Trinh et al 2014a</xref>]. </p>
          <p>Ethnic background may also be a factor in penetrance. Norwegians showed a significantly reduced cumulative incidence estimate compared to Tunisian Arab Berbers. However, Israeli Ashkenazi Jewish individuals heterozygous for the <italic toggle="yes">LRRK2</italic> p.Gly2019Ser pathogenic variant had comparable estimates to Tunisian Arab Berbers [<xref ref-type="bibr" rid="lrrk2.REF.hentati.2014.568">Hentati et al 2014</xref>, <xref ref-type="bibr" rid="lrrk2.REF.trinh.2014a.1125">Trinh et al 2014a</xref>]. Curiously, penetrance in a New York Ashkenazi Jewish cohort is even more reduced than in a cohort of individuals from Norway [<xref ref-type="bibr" rid="lrrk2.REF.clark.2006.1786">Clark et al 2006</xref>]. While bias in ascertainment and reporting likely contributes to this figure, the identification of genetic and/or environmental modifiers of penetrance and disease susceptibility are currently under investigation.</p>
          <p>Penetrance estimates for <italic toggle="yes">LRRK2</italic> p.Gly2019Ser are most widely reported, but pedigree-based figures for <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1441Cys</xref> are similar [<xref ref-type="bibr" rid="lrrk2.REF.haugarvoll.2008.1456">Haugarvoll et al 2008</xref>].</p>
        </sec>
        <sec id="lrrk2.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation is a phenomenon whereby the symptoms of a genetic disorder become apparent at an earlier age as it is passed on to the next generation. In most cases, an increase of severity of symptoms is also noted. This usually occurs with unstable repeat disorders, e.g., <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>. Anticipation has not been documented in <italic toggle="yes">LRRK2</italic>-related PD and is unlikely, although suggested in a few families [<xref ref-type="bibr" rid="lrrk2.REF.khan.2005.2786">Khan et al 2005</xref>].</p>
        </sec>
        <sec id="lrrk2.Nomenclature">
          <title>Nomenclature</title>
          <p>The term PARK8 refers to the chromosomal region of 12q12 linked to disease in a large Japanese PD kindred [<xref ref-type="bibr" rid="lrrk2.REF.funayama.2002.296">Funayama et al 2002</xref>]. Once the associated gene and the specific pathogenic variant were identified, the term became superfluous.</p>
          <p>The Basque word for tremor, &#x02018;dardarin,&#x02019; has been used to refer to <italic toggle="yes">LRRK2</italic>-related PD cause by the pathogenic <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">p.Arg1441Gly</xref> variant.</p>
        </sec>
        <sec id="lrrk2.Prevalence">
          <title>Prevalence</title>
          <p>In the US, <italic toggle="yes">LRRK2</italic>-related Parkinson disease causes approximately 1.0% of simplex PD (i.e. single occurrences in a family) and approximately 5%-6% of familial PD.</p>
          <p><italic toggle="yes">LRRK2</italic> p.Gly2019Ser is the most common pathogenic variant, accounting for the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 0.5% of simplex PD and 2%-6% of familial PD in the US [<xref ref-type="bibr" rid="lrrk2.REF.deng.2005.933">Deng et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.farrer.2005.738">Farrer et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.nichols.2005.410">Nichols et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.kay.2006.519">Kay et al 2006</xref>] </p>
            </list-item>
            <list-item>
              <p>Approximately 0.5% of simplex PD in the UK [<xref ref-type="bibr" rid="lrrk2.REF.williamsgray.2006.665">Williams-Gray et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>Approximately 2% in families from central Norway [<xref ref-type="bibr" rid="lrrk2.REF.aasly.2005.762">Aasly et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p>0.9% simplex PD and 5.1% familial PD in Italy [<xref ref-type="bibr" rid="lrrk2.REF.goldwurm.2005.e65">Goldwurm et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p>2.7%-7.6% in northern Spain [<xref ref-type="bibr" rid="lrrk2.REF.mata.2006a.391">Mata et al 2006a</xref>]</p>
            </list-item>
            <list-item>
              <p>Approximately 30% of simplex PD [<xref ref-type="bibr" rid="lrrk2.REF.gaig.2006.377">Gaig et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.infante.2006.224">Infante et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.hulihan.2008.591">Hulihan et al 2008</xref>] and up to 41% of familial PD in North Africa (Morocco, Algeria, and Tunisia) [<xref ref-type="bibr" rid="lrrk2.REF.lesage.2006.422">Lesage et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.hulihan.2008.591">Hulihan et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Approximately 18% of PD in Ashkenazi Jews (13% of simplex cases and 30% of familial cases) [<xref ref-type="bibr" rid="lrrk2.REF.ozelius.2006.424">Ozelius et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>0.4% of simplex PD in Japan [<xref ref-type="bibr" rid="lrrk2.REF.zabetian.2006.697">Zabetian et al 2006</xref>]Note: (1) p.Gly2019Ser was reported in a Japanese individual with PD in another study [<xref ref-type="bibr" rid="lrrk2.REF.tomiyama.2006.1102">Tomiyama et al 2006</xref>]. In that study, however, the frequency of p.Gly2019Ser was reported in a pooled Asian sample and the frequency among Japanese individuals with PD was not specified. (2) p.Gly2019Ser has not been identified in over 1,200 individuals with PD of Chinese ancestry screened to date [<xref ref-type="bibr" rid="lrrk2.REF.lu.2005.521">Lu et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.tan.2006.857">Tan et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.tomiyama.2006.1102">Tomiyama et al 2006</xref>]. Combining all Asian populations into a single group is not advisable; therefore, it is quite possible that p.Gly2019Ser occurs among the Japanese but not in other Asian populations.</p>
            </list-item>
          </list>
          <p>These frequencies have largely been extrapolated from clinic and/or community-based series, but in the US they are in close agreement with incidence-based samples [unpublished data].</p>
          <p>Asymptomatic heterozygotes (including 1 person age 91 years) are noted within families, typically ascertained via an affected proband [<xref ref-type="bibr" rid="lrrk2.REF.gaig.2006.377">Gaig et al 2006</xref>]; however, pathogenic <italic toggle="yes">LRRK2</italic> variants have negligible frequency in age-/gender-matched population controls [<xref ref-type="bibr" rid="lrrk2.REF.kachergus.2005.672">Kachergus et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.mata.2005a.171">Mata et al 2005a</xref>, <xref ref-type="bibr" rid="lrrk2.REF.hulihan.2008.591">Hulihan et al 2008</xref>]. Among unselected individuals of Ashkenazi Jewish ancestry, the prevalence of p.Gly2019Ser is likely 1%-2% [<xref ref-type="bibr" rid="lrrk2.REF.ozelius.2006.424">Ozelius et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.saunderspullman.2006.92">Saunders-Pullman et al 2006</xref>].</p>
          <p>The p.Arg1441Gly pathogenic variant, present in approximately 8% of individuals with PD from the Basque community in northern Spain, probably represents a founder mutation as it has not been reported outside of Spanish-speaking communities [<xref ref-type="bibr" rid="lrrk2.REF.paisanruiz.2004.595">Paisan-Ruiz et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.mata.2005b.309">Mata et al 2005b</xref>, <xref ref-type="bibr" rid="lrrk2.REF.deng.2006.102">Deng et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.simonsanchez.2006.1954">Sim&#x000f3;n-S&#x000e1;nchez et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gonzalezfernandez.2007.509">Gonz&#x000e1;lez-Fern&#x000e1;ndez et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.mata.2009.370">Mata et al 2009</xref>]. It is estimated that the most recent common ancestor lived 1350 (95% CI, 1020-1740) years ago (~7th century), suggesting that p.Arg1441Gly originated in the Basque population and that dispersion of the pathogenic variant then occurred through short-range gene flow that was largely limited to nearby regions in Spain [<xref ref-type="bibr" rid="lrrk2.REF.mata.2009.370">Mata et al 2009</xref>].</p>
        </sec>
      </sec>
      <sec id="lrrk2.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>A small number of individuals with a <italic toggle="yes">LRRK2</italic> pathogenic variant have presented with atypical symptoms including progressive supranuclear palsy- and amyotrophic lateral sclerosis-like signs or alternate neurodegenerative disorders including Alzheimer disease and frontotemporal dementia [<xref ref-type="bibr" rid="lrrk2.REF.zimprich.2004.601">Zimprich et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ross.2006.388">Ross et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.dachsel.2007a.601">D&#x000e4;chsel et al 2007a</xref>, <xref ref-type="bibr" rid="lrrk2.REF.santosreboucas.2008.471">Santos-Rebou&#x000e7;as et al 2008</xref>]. However, the small number of cases identified makes it difficult to determine if these findings result from Lrrk2 dysfunction or are merely coincidental. </p>
      </sec>
      <sec id="lrrk2.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Parkinson disease multi-gene panels may include testing for a number of genes associated with disorders in the differential diagnosis for <italic toggle="yes">LRRK2</italic>-related Parkinson disease (PD). See <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>. </p>
        <p><italic toggle="yes">LRRK2</italic>-related Parkinson disease (PD) is indistinguishable from PD of unknown cause (see <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>). However, molecular genetic testing provides a definitive diagnosis.</p>
      </sec>
      <sec id="lrrk2.Management">
        <title>Management</title>
        <sec id="lrrk2.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">LRRK2</italic>-related Parkinson disease (PD), neurologic examination should include assessment of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Tremor</p>
            </list-item>
            <list-item>
              <p>Rigidity</p>
            </list-item>
            <list-item>
              <p>Bradykinesia</p>
            </list-item>
            <list-item>
              <p>Gait</p>
            </list-item>
            <list-item>
              <p>Mental status</p>
            </list-item>
          </list>
          <p>Medical genetics consultation may also be considered.</p>
        </sec>
        <sec id="lrrk2.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The treatment of individuals with <italic toggle="yes">LRRK2</italic>-related PD does not differ from that of idiopathic PD.</p>
          <p>The mainstay of treatment is pharmacologic replacement of dopamine, most commonly accomplished with the precursor of dopamine, L-dopa, combined with carbi-dopa.</p>
          <p>Dopamine agonists may also be used, as well as inhibitors of catechol-O-methyltransferase (COMT) or monoamine oxidase-B (MAO-B).</p>
          <p>The motor impairment generally responds well to dopamine therapy (agonists and levodopa). </p>
          <p>Other medications include anticholinergics, selegiline, and amantadine [<xref ref-type="bibr" rid="lrrk2.REF.lang.1998a.1044">Lang &#x00026; Lozano 1998a</xref>, <xref ref-type="bibr" rid="lrrk2.REF.lang.1998b.1130">Lang &#x00026; Lozano 1998b</xref>, <xref ref-type="bibr" rid="lrrk2.REF.hristova.2000.165">Hristova &#x00026; Koller 2000</xref>, <xref ref-type="bibr" rid="lrrk2.REF.marjamalyons.2001.24">Marjama-Lyons &#x00026; Koller 2001</xref>, <xref ref-type="bibr" rid="lrrk2.REF.olanow.2004.72">Olanow &#x00026; Stocchi 2004</xref>].</p>
          <p>Neurosurgical procedures such as deep brain stimulation of the subthalamic nucleus/globus pallidus interna or pallido-pontine nucleus benefit some individuals in whom dyskinesias or gait disoders are especially problematic. Less commonly, pallidotomy (or, rarely, fetal brain transplant to the caudate nucleus) may also provide benefit [<xref ref-type="bibr" rid="lrrk2.REF.esselink.2004.201">Esselink et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.schupbach.2007.119">Sch&#x000fc;pbach et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gomezesteban.2008.857">G&#x000f3;mez-Esteban et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.munhoz.2009.791">Munhoz et al 2009</xref>].</p>
          <p>Individuals with Parkinson disease may benefit from physical, occupational, and speech therapy.</p>
          <p>To date, limited effective treatment exists for non-motor findings, which can be extremely disabling.</p>
        </sec>
        <sec id="lrrk2.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>The most common complication from L-dopa therapy is dyskinesias, for which deep-brain stimulation has proven helpful [<xref ref-type="bibr" rid="lrrk2.REF.aasly.2005.762">Aasly et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gosal.2005.349">Gosal et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.hernandez.2005.453">Hernandez et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.goldwurm.2006.410">Goldwurm et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ishihara.2006.1250">Ishihara et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.tomiyama.2006.1102">Tomiyama et al 2006</xref>].</p>
          <p>Other preventions for L-dopa induced dyskinesias include constant drug delivery/stimulation (CDD/CDS) [<xref ref-type="bibr" rid="lrrk2.REF.jenner.2008.S585">Jenner 2008</xref>], reduction of levodopa doses [<xref ref-type="bibr" rid="lrrk2.REF.goetz.1982.351">Goetz et al 1982</xref>] and the use of dopamine receptor agonists [<xref ref-type="bibr" rid="lrrk2.REF.holloway.2004.15">Holloway &#x00026; Frank 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.holloway.2004.1044">Holloway et al 2004</xref>].</p>
        </sec>
        <sec id="lrrk2.Surveillance">
          <title>Surveillance</title>
          <p>Annual neurologic examination should assess gait, tremor, rigidity, cognition, and mood.</p>
        </sec>
        <sec id="lrrk2.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Neuroleptic treatment may exacerbate parkinsonism in <italic toggle="yes">LRRK2</italic>-related PD, as in PD in general.</p>
        </sec>
        <sec id="lrrk2.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="lrrk2.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="lrrk2.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Lrrk2 protein is a fusion of Rab (Roc), COR and kinase (MAPK) domains, and pathogenic variants are postulated to augment kinase activity [<xref ref-type="bibr" rid="lrrk2.REF.kachergus.2005.672">Kachergus et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.west.2005.16842">West et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gloeckner.2006.223">Gloeckner et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.greggio.2006.329">Greggio et al 2006</xref>]. Hence, the development of specific kinase inhibitors offers an attractive therapeutic target for neuroprotection in asymptomatic and affected <italic toggle="yes">LRRK2</italic> heterozygotes, and for idiopathic PD [<xref ref-type="bibr" rid="lrrk2.REF.albrecht.2005.1230">Albrecht 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.toft.2005.1229">Toft et al 2005</xref>]. A number of inhibitors are being developed; however, selectivity, specificity, and delivery into the central nervous system remain difficult issues to address [<xref ref-type="bibr" rid="lrrk2.REF.lee.2010b.998">Lee et al 2010b</xref>]. Moreover, <italic toggle="yes">LRRK2</italic> kinase inhibition may lead to complications that affect the lung and kidney [<xref ref-type="bibr" rid="lrrk2.REF.herzig.2011.4209">Herzig et al 2011</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="lrrk2.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="lrrk2.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">LRRK2</italic>-related Parkinson disease (PD) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="lrrk2.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with <italic toggle="yes">LRRK2</italic>-related Parkinson disease have one parent who has a <italic toggle="yes">LRRK2</italic> pathogenic variant. However, given the reduced penetrance associated with <italic toggle="yes">LRRK2</italic>-related PD, a high percentage of affected individuals report unaffected parents. </p>
            </list-item>
            <list-item>
              <p>The probability that an asymptomatic parent with a pathogenic variant will become symptomatic increases with age.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or <italic toggle="yes">de novo</italic> mutation in the proband. </p>
              <list list-type="bullet">
                <list-item>
                  <p>Although no instances of germline mosaicism have been reported, it remains a possibility. </p>
                </list-item>
                <list-item>
                  <p><italic toggle="yes">De novo</italic> mutation may occur; thus far it has not been described. Some sites within the gene may be highly mutable, notably the arginine codon at residue 1441, in which three amino acid changes have been reported to be pathogenic.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: Even if an individual diagnosed with <italic toggle="yes">LRRK2</italic>-related PD has a parent who has the <italic toggle="yes">LRRK2</italic> pathogenic variant, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, reduced penetrance, or late onset of the disease in the affected parent.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected or has a pathogenic variant, the risk to the sibs of inheriting the pathogenic variant is 50%. However, the risk to sibs of developing disease is lower than 50% because of age-related penetrance (see <xref ref-type="sec" rid="lrrk2.Penetrance">Penetrance</xref>).</p>
            </list-item>
            <list-item>
              <p>The probability that an asymptomatic sib who has the pathogenic variant will become symptomatic increases with age.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with <italic toggle="yes">LRRK2</italic>-related PD has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The probability that an offspring with a pathogenic variant will become symptomatic increases with age.</p>
            </list-item>
          </list>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent is affected or has a pathogenic variant, his or her family members may be at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="lrrk2.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with <italic toggle="yes">LRRK2</italic>-related PD is possible after molecular genetic testing has identified the specific pathogenic variant in the family. Such testing should be performed in the context of formal genetic counseling and is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. </p>
          <p>Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing. At-risk asymptomatic adult family members may seek testing in order to make personal decisions regarding reproduction, financial matters, and career planning. Others may have different motivations including simply the "need to know." Testing of asymptomatic at-risk adult family members usually involves pre-test interviews in which the motives for requesting the test, the individual's knowledge of <italic toggle="yes">LRRK2</italic>-related PD, the possible impact of positive and negative test results, and neurologic status are assessed. Those seeking testing should be counseled about possible problems that they may encounter with regard to health, life, and disability insurance coverage, employment and educational discrimination, and changes in social and family interaction. Other issues to consider are implications for the at-risk status of other family members. Informed consent should be procured and records kept confidential. Individuals with a positive test result need arrangements for long-term follow up and evaluations.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause. </p>
          <p>In a family with an established diagnosis of <italic toggle="yes">LRRK2</italic>-related PD, testing is appropriate to consider in symptomatic individuals regardless of age. </p>
          <p>For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo LRRK2</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="lrrk2.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">LRRK2</italic> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing. </p>
          <p>Requests for prenatal testing for adult-onset conditions such as <italic toggle="yes">LRRK2</italic>-related PD are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">LRRK2</italic> pathogenic variant has been identified. </p>
        </sec>
      </sec>
      <sec id="lrrk2.Resources">
        <title>Resources</title>
      </sec>
      <sec id="lrrk2.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">LRRK2</italic> comprises 144 kb and 51 exons. There is only one transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&#x00026;db=Nucleotide&#x00026;term=NM_198578&#x00026;doptcmdl=GenBank&#x00026;tool=genome.ucsc.edu">NM_198578.3</ext-link>. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="lrrk2" object-id="lrrk2.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Allelic variants.</bold> Pathogenic <italic toggle="yes">LRRK2</italic> variants are listed in <xref ref-type="table" rid="lrrk2.T.selected_lrrk2_allelic_variants">Table 3</xref>; see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="PDF File" xlink:href="lrrk2-table3a.pdf" content-type="local-data">Table 3a</inline-supplementary-material> (pdf) for additional information (exon, domain, and rs#).</p>
        <p>As the pathogenicity of many <italic toggle="yes">LRRK2</italic> variants has not been determined to date, other known variants are listed as nonsynonymous and silent allelic variants. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="PDF File" xlink:href="lrrk2-tables4-5.pdf" content-type="local-data">Tables 4 and 5</inline-supplementary-material> (pdf).</p>
        <table-wrap id="lrrk2.T.selected_lrrk2_allelic_variants" position="anchor" orientation="portrait">
          <label>Table 3.</label>
          <caption>
            <p>Selected <italic toggle="yes">LRRK2</italic> Allelic Variants</p>
          </caption>
          <table>
            <tbody>
              <tr>
                <th id="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">Class of Variant</th>
                <th id="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequence</th>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_1" align="left" valign="middle" rowspan="9" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.4309A&#x0003e;C</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Asn1437His&#x000a0;<sup>1</sup></td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="11" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/171846277">NM_198578.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/171846278">NP_940980.3</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.4322G&#x0003e;A</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg1441His&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.4321C&#x0003e;T</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg1441Cys</td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.4321C&#x0003e;G</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg1441Gly</td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.4883G&#x0003e;C </td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Arg1628Pro&#x000a0;<sup>3</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.5096A&#x0003e;G</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Tyr1699Cys</td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.6055G&#x0003e;A</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Gly2019Ser</td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.6059T&#x0003e;C</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Ile2020Thr</td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.7153G&#x0003e;A</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Gly2385Arg&#x000a0;<sup>3</sup></td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                  <bold>Likely Pathogenic</bold>
                </td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.4324G&#x0003e;C</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Ala1442Pro</td>
              </tr>
              <tr>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.6035T&#x0003e;C</td>
                <td headers="hd_b_lrrk2.T.selected_lrrk2_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Ile2012Thr</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="lrrk2.TF.3">
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
            </fn>
            <fn id="lrrk2.TF.3.1">
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature. </p>
            </fn>
            <fn id="lrrk2.TF.3.2">
              <p>1. <xref ref-type="bibr" rid="lrrk2.REF.aasly.2010.2156">Aasly et al [2010]</xref></p>
            </fn>
            <fn id="lrrk2.TF.3.3">
              <p>2. <xref ref-type="bibr" rid="lrrk2.REF.ross.2009.466">Ross et al [2009]</xref></p>
            </fn>
            <fn id="lrrk2.TF.3.4">
              <p>3. Less penetrant pathogenic variants (2-fold risk) specific to Asian communities that are also common; &#x0003e;1% in the healthy population</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Genetic risk factors.</bold> Recent large genome-wide association studies have shown the <italic toggle="yes">LRRK2</italic> locus to contain population-based common risk factors for disease, as previously highlighted by p.Arg1628Pro and p.Gly2385Arg [<xref ref-type="bibr" rid="lrrk2.REF.internationalparkinso.2011.641">International Parkinson Disease Genomics Consortium 2011</xref>, <xref ref-type="bibr" rid="lrrk2.REF.lill.2012.e1002548">Lill et al 2012</xref>].</p>
        <p>A large collaborative effort by the Genetic Epidemiology of Parkinson&#x02019;s Disease consortium (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.geopd.org/">GEO-PD</ext-link>) that included investigators from 23 sites representing 15 countries on five continents examined the role of <italic toggle="yes">LRRK2</italic> coding variants. Investigators contributed clinical samples on 15,540 individuals (8,611 persons with PD and 6,929 controls). The study identified two novel risk factors &#x02013; p.Ala419Val in Asian populations and Met1646Thr in populations of northern European heritage &#x02013; and a common <italic toggle="yes">LRRK2</italic> protective haplotype (Asp551Lys-Arg1398His-Lys1423Lys), suggesting that the toxic nature of the protein can be manipulated and providing hope for future neuroprotective therapy [<xref ref-type="bibr" rid="lrrk2.REF.tan.2010.561">Tan et al 2010</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ross.2011.898">Ross et al 2011</xref>]. </p>
        <p><bold>Normal gene product.</bold> The normal gene product, leucine-rich repeat serine/threonine-protein kinase 2 (Lrrk2), is a 2527-amino acid protein (286 kd) that shares homology with the Roco family of proteins. The six conserved domains within this class of Roco proteins are: ankyrin repeat, leucine-rich repeat, Roc, COR, MAPKKK, and WD40 (see <xref ref-type="fig" rid="lrrk2.F1">Figure 1</xref>) [<xref ref-type="bibr" rid="lrrk2.REF.bosgraaf.2003.5">Bosgraaf &#x00026; Van Haastert 2003</xref>, <xref ref-type="bibr" rid="lrrk2.REF.mata.2006b.286">Mata et al 2006b</xref>]. Given the size, domain composition and organization of Lrrk2, and the potential for protein-protein interactions, it is likely to be part of a higher molecular-weight complex involved in cellular signaling. Monomers of Lrrk2 protein may also dimerize, similar to the conformation adopted by most protein kinases and Ras GTPases [<xref ref-type="bibr" rid="lrrk2.REF.gloeckner.2006.223">Gloeckner et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.dachsel.2007b.382">D&#x000e4;chsel et al 2007b</xref>, <xref ref-type="bibr" rid="lrrk2.REF.deng.2008.1499">Deng et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.greggio.2008.16906">Greggio et al 2008</xref>].</p>
        <p>Several biochemical studies have since confirmed kinase activity for Lrrk2 wild type protein and a number of substrates or cofactors have been nominated [<xref ref-type="bibr" rid="lrrk2.REF.west.2005.16842">West et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gloeckner.2006.223">Gloeckner et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.greggio.2006.329">Greggio et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.iaccarino.2007.1319">Iaccarino et al 2007</xref>]. These include threonine 558 of moesin, a member of the ERM/merlin family that links plasma membrane receptor complexes to the microfilament cytoskeleton [<xref ref-type="bibr" rid="lrrk2.REF.jaleel.2007.307">Jaleel et al 2007</xref>]. In <italic toggle="yes">Drosophila</italic>, Lrrk2 has also been shown to interact with the insulin/IGF signaling pathway to enhance 4E-BP phosphorylation at theonine 37/46, a negative regulator of eIF4E-mediated protein translation that is critical in stress response and dopaminergic neuronal maintenance [<xref ref-type="bibr" rid="lrrk2.REF.imai.2008.2432">Imai et al 2008</xref>]. Whether these are true substrates in vivo has yet to be demonstrated, as does their relevance to PD. </p>
        <p>Several groups have shown that Lrrk2 GTP binding and GTPase activity have a modifying effect on kinase activity [<xref ref-type="bibr" rid="lrrk2.REF.guo.2007.3658">Guo et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.lewis.2007.668">Lewis et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.li.2007.238">Li et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.vanegmond.2008.30412">van Egmond et al 2008</xref>]. The Roc-COR domain may also require dimerization for optimal GTPase activity [<xref ref-type="bibr" rid="lrrk2.REF.deng.2008.1499">Deng et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gotthardt.2008.2352">Gotthardt et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.greggio.2008.16906">Greggio et al 2008</xref>].</p>
        <p><bold>Abnormal gene product.</bold> It is postulated that mutant leucine-rich repeat serine/threonine-protein kinase 2 proteins augment MAPK activity, resulting in a toxic gain of function; experimental data now provide some support for this pathogenic mechanism [<xref ref-type="bibr" rid="lrrk2.REF.smith.2005.18676">Smith et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.greggio.2006.329">Greggio et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.mata.2006b.286">Mata et al 2006b</xref>]. </p>
        <p>Lrrk2 p.Gly2019Ser is within exon 41 and the &#x02018;activation hinge&#x02019; of the MAPK domain and is associated with a two- to threefold increase of intra- and intermolecular phosphorylation [<xref ref-type="bibr" rid="lrrk2.REF.west.2005.16842">West et al 2005</xref>, <xref ref-type="bibr" rid="lrrk2.REF.greggio.2006.329">Greggio et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.macleod.2006.587">MacLeod et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.smith.2006.1231">Smith et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.jaleel.2007.307">Jaleel et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.luzontoro.2007.2031">Luz&#x000f3;n-Toro et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.anand.2009.466">Anand et al 2009</xref>]. Whether enhanced kinase activity in vivo represents a characteristic feature shared by all pathogenic Lrrk2 variants remains controversial [<xref ref-type="bibr" rid="lrrk2.REF.jaleel.2007.307">Jaleel et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.anand.2009.466">Anand et al 2009</xref>]. The Lrrk2 p.Ile2020Thr substitution and the adjacent p.Gly2019Ser also both provide a potential site for phosphorylation [<xref ref-type="bibr" rid="lrrk2.REF.zimprich.2004.601">Zimprich et al 2004</xref>, <xref ref-type="bibr" rid="lrrk2.REF.funayama.2005.918">Funayama et al 2005</xref>]. Lrrk2 p.Arg1441Cys, Gly, and His substitutions affect the same arginine residue in the Roc domain, a &#x02018;Ras-like&#x02019; part of the protein, that binds and hydrolyses GTP and appears to be a prerequisite for Lrrk2 kinase activity [<xref ref-type="bibr" rid="lrrk2.REF.mata.2006b.286">Mata et al 2006b</xref>, <xref ref-type="bibr" rid="lrrk2.REF.ito.2007.1380">Ito et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.lewis.2007.668">Lewis et al 2007</xref>, <xref ref-type="bibr" rid="lrrk2.REF.greggio.2008.16906">Greggio et al 2008</xref>]. Lrrk2 p.Arg1628Pro and p.Tyr1699Cys are located within the COR domain that bridges Roc and MAPK domains, whereas p.Gly2385Arg is located on the external surface of the C-terminal WD40 &#x02018;barrel,&#x02019; a motif with multiple binding surfaces that usually facilitates protein-protein interactions [<xref ref-type="bibr" rid="lrrk2.REF.mata.2006b.286">Mata et al 2006b</xref>].</p>
        <p>In retinoic acid-differentiated SH-SY5Y, primary neuronal cultures, and in the intact rodent CNS the over-expression of Lrrk2 mutants induces a progressive reduction in neuritic length and branching [<xref ref-type="bibr" rid="lrrk2.REF.macleod.2006.587">MacLeod et al 2006</xref>, <xref ref-type="bibr" rid="lrrk2.REF.plowey.2008.1048">Plowey et al 2008</xref>, <xref ref-type="bibr" rid="lrrk2.REF.dachsel.2010.650">D&#x000e4;chsel et al 2010</xref>]. In contrast, Lrrk2 knockdown induced by RNA interference, or over-expression of a Lrrk2 variant with deficient kinase activity, confers increased neuritic length and branching [<xref ref-type="bibr" rid="lrrk2.REF.macleod.2006.587">MacLeod et al 2006</xref>]. In the same model, expression of pathogenic Lrrk2 variants linked to PD may lead to prominent phospho-tau immuno-positive inclusions, with lysosomal characteristics, concomitant with apoptosis [<xref ref-type="bibr" rid="lrrk2.REF.macleod.2006.587">MacLeod et al 2006</xref>]. A BAC mouse model overexpressing the human <italic toggle="yes">LRRK2</italic> p.Arg1441Gly pathogenic variant has been reported to have a deficit in dopamine release, a progressive movement disorder leading to akinesia, and tau pathology [<xref ref-type="bibr" rid="lrrk2.REF.li.2009.826">Li et al 2009</xref>].</p>
        <p>Recent studies have implicated mutant <italic toggle="yes">LRRK2</italic> in a number of different pathways including autophagy, endosomal-lysosomal function, and Wnt signaling [<xref ref-type="bibr" rid="lrrk2.REF.berwick.2011.257">Berwick &#x00026; Harvey 2011</xref>, <xref ref-type="bibr" rid="lrrk2.REF.berwick.2012.4966">Berwick &#x00026; Harvey 2012</xref>, <xref ref-type="bibr" rid="lrrk2.REF.friedman.2012.7585">Friedman et al 2012</xref>, <xref ref-type="bibr" rid="lrrk2.REF.gomezsuaga.2012.692">G&#x000f3;mez-Suaga &#x00026; Hilfiker 2012</xref>, <xref ref-type="bibr" rid="lrrk2.REF.tong.2012.2">Tong et al 2012</xref>, <xref ref-type="bibr" rid="lrrk2.REF.bravosanpedro.2013.121">Bravo-San Pedro et al 2013</xref>]. </p>
        <p><italic toggle="yes">LRRK2</italic> has also been shown to play an important function at the synapse and may play a role in vesicle recycling [<xref ref-type="bibr" rid="lrrk2.REF.lee.2010a.16959">Lee et al 2010a</xref>, <xref ref-type="bibr" rid="lrrk2.REF.piccoli.2011.2225">Piccoli et al 2011</xref>]. <italic toggle="yes">LRRK2</italic> p.Gly2019Ser has been shown to increase the probability of striatal glutamate release [<xref ref-type="bibr" rid="lrrk2.REF.beccanokelly.2014.1">Beccano-Kelly et al 2014</xref>].</p>
      </sec>
      <sec id="lrrk2.References">
        <title>References</title>
        <sec id="lrrk2.Published_GuidelinesConsensus_Stat">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="lrrk2.Published_GuidelinesConsensus_Stat.reflist0">
            <ref id="lrrk2.REF.americansocietyofhumang.1995.1">
              <mixed-citation publication-type="book">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 2-18-15.</mixed-citation>
            </ref>
            <ref id="lrrk2.REF.nationalsocietyofgeneti.2012.1">
              <mixed-citation publication-type="book">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 12-4-14.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="lrrk2.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="lrrk2.Literature_Cited.reflist0">
            <ref id="lrrk2.REF.aasly.2005.762">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Mata</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical features of LRRK2-associated Parkinson's disease in central Norway.</article-title>
                <source>Ann Neurol</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>762</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15852371</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.aasly.2010.2156">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilari&#x000f1;o-G&#x000fc;ell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dachsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webber</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haugarvoll</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johansen</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nutt</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soto-Ortolaza</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobb</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.</article-title>
                <source>Mov Disord.</source>
                <year>2010</year>
                <volume>25</volume>
                <fpage>2156</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">20669305</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.adams.2005.2777">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Netten</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mckenzie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strongosky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sossi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruth</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.</article-title>
                <source>Brain</source>
                <year>2005</year>
                <volume>128</volume>
                <fpage>2777</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">16081470</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.albrecht.2005.1230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 mutations and Parkinsonism.</article-title>
                <source>Lancet</source>
                <year>2005</year>
                <volume>365</volume>
                <fpage>1230</fpage>
                <pub-id pub-id-type="pmid">15811455</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.alcalay.2013.1966">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alcalay</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirelman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>MX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mejia Santana</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orbe-Reilly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurevich</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bar Shira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gana Weisz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasinovsky</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zalis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thaler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deik</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabassa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groves</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunt</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubarr</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>San Luciano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miravite</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmese</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachdev</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarva</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Severt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanker</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swan</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soto-Valencia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johannes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortega</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cote</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosado</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorovski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauciulo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orr-Urtreger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giladi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marder</surname>
                    <given-names>KS</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.</article-title>
                <source>Mov Disord</source>
                <year>2013</year>
                <volume>14</volume>
                <fpage>1966</fpage>
                <lpage>71</lpage>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.alegreabarrategui.2008.272">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alegre-Abarrategui</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ansorge</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esiri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wade-Martins</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.</article-title>
                <source>Neuropathol Appl Neurobiol</source>
                <year>2008</year>
                <volume>34</volume>
                <fpage>272</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">17971075</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.anand.2009.466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anand</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichling</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipinski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stochaj</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelleher</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pungaliya</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinhart</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirst</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddle</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braithwaite</surname>
                    <given-names>SP</given-names>
                  </name>
                </person-group>
                <article-title>Investigation of leucine-rich repeat kinase 2: enzymological properties and novel assays.</article-title>
                <source>FEBS J</source>
                <year>2009</year>
                <volume>276</volume>
                <fpage>466</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">19076219</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.beccanokelly.2014.1">
              <mixed-citation publication-type="book">Beccano-Kelly DA, Volta M, Munsie LN, Paschall SA, Tatarnikov I, Co K, Chou P, Cao LP, Bergeron S, Mitchell E, Han H, Melrose HL, Tapia L, Raymond LA, Farrer MJ, Milnerwood AJ. LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory. Hum Mol Genet. 2014 Oct 24. pii: ddu543</mixed-citation>
            </ref>
            <ref id="lrrk2.REF.berwick.2012.4966">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berwick</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2012</year>
                <volume>21</volume>
                <fpage>4966</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">22899650</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.berwick.2011.257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berwick</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 signaling pathways: the key to unlocking neurodegeneration?</article-title>
                <source>Trends Cell Biol.</source>
                <year>2011</year>
                <volume>21</volume>
                <fpage>257</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">21306901</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.biskup.2007.102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rea</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz-Deperieux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coombes</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <article-title>Dynamic and redundant regulation of LRRK2 and LRRK1 expression.</article-title>
                <source>BMC Neurosci</source>
                <year>2007</year>
                <volume>8</volume>
                <fpage>102</fpage>
                <pub-id pub-id-type="pmid">18045479</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.bosgraaf.2003.5">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bosgraaf</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Haastert</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <article-title>Roc, a Ras/GTPase domain in complex proteins.</article-title>
                <source>Biochim Biophys Acta</source>
                <year>2003</year>
                <volume>1643</volume>
                <fpage>5</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">14654223</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.bravosanpedro.2013.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bravo-San Pedro</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niso-Santano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-S&#x000e1;nchez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizarro-Estrella</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aiastui-Pujana</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorostidi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Climent</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Maturana</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Pernaute</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuentes</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Polo</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.</article-title>
                <source>Cell Mol Life Sci.</source>
                <year>2013</year>
                <volume>70</volume>
                <fpage>121</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">22773119</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.carminebelin.2006.1731">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carmine Belin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westerlund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sydow</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundstr&#x000f6;mer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e5;kansson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nissbrandt</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galter</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.</article-title>
                <source>Mov Disord.</source>
                <year>2006</year>
                <volume>21</volume>
                <issue>10</issue>
                <fpage>1731</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16817197</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.chaudhuri.2006.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaudhuri</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healy</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapira</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <article-title>Non-motor symptoms of Parkinson's disease: diagnosis and management.</article-title>
                <source>Lancet Neurol</source>
                <year>2006</year>
                <volume>5</volume>
                <fpage>235</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">16488379</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.cilia.2014.911">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cilia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rusconi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allegra</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiglietti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacilotto</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecchinelli</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asselta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paganoni</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 mutations in Parkinson&#x02019;s disease: confirmation of a gender effect in the Italian population.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2014</year>
                <volume>20</volume>
                <fpage>911</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24816003</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.clark.2006.1786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>LN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlins</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mejia-Santana</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louis</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cote</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frucht</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marder</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.</article-title>
                <source>Neurology</source>
                <year>2006</year>
                <volume>67</volume>
                <fpage>1786</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">17050822</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.covy.2009.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Covy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurtig</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deerlin</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giasson</surname>
                    <given-names>BI</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations.</article-title>
                <source>Mov Disord</source>
                <year>2009</year>
                <volume>24</volume>
                <fpage>32</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19006185</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.dachsel.2010.650">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x000e4;chsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behrouz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beevers</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melrose</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>A comparative study of Lrrk2 function in primary neuronal cultures.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2010</year>
                <volume>16</volume>
                <issue>10</issue>
                <fpage>650</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20850369</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.dachsel.2007a.601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x000e4;chsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions.</article-title>
                <source>Acta Neuropathol</source>
                <year>2007a</year>
                <volume>113</volume>
                <fpage>601</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17151837</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.dachsel.2007b.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x000e4;chsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mok</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinkle</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailey</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hines</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szutu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madden</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrucelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Identification of potential protein interactors of Lrrk2.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2007b</year>
                <volume>13</volume>
                <fpage>382</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17400507</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.deng.2006.102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankovic</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Genetic analysis of LRRK2 mutations in patients with Parkinson disease.</article-title>
                <source>J Neurol Sci</source>
                <year>2006</year>
                <volume>251</volume>
                <fpage>102</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17097110</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.deng.2005.933">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankovic</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation.</article-title>
                <source>Ann Neurol</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>933</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15929036</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.deng.2008.1499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greggio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sluch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beilina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cookson</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <year>2008</year>
                <volume>105</volume>
                <fpage>1499</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">18230735</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.difonzo.2005.412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Fonzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohe</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vacca</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stocchi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guedes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabrizio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manfredi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanacore</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampaio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meco</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbosa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.</article-title>
                <source>Lancet</source>
                <year>2005</year>
                <volume>365</volume>
                <fpage>412</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15680456</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.difonzo.2006a.322">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Fonzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassorelli</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Mari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohe</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riboldazzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mauro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbruzzese</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopiano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fincati</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guidi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stocchi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onofrj</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toni</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinazzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabbrini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamberti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanacore</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meco</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leitner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampaio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbosa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martignoni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.</article-title>
                <source>Eur J Hum Genet</source>
                <year>2006a</year>
                <volume>14</volume>
                <fpage>322</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">16333314</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.difonzo.2006b.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Fonzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu-Chou</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Doeselaar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohe</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weng</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanacore</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.</article-title>
                <source>Neurogenetics</source>
                <year>2006b</year>
                <volume>7</volume>
                <fpage>133</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16633828</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.esselink.2004.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Esselink</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bie</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Haan</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenders</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijssen</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staal</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeding</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuurman</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosch</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speelman</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <article-title>Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial.</article-title>
                <source>Neurology</source>
                <year>2004</year>
                <volume>62</volume>
                <fpage>201</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14745054</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.estanga.2014.1097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Estanga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Oroz</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Martinez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barandiaran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorostidi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergareche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mondragon</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti-Masso</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <article-title>Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2014</year>
                <volume>20</volume>
                <issue>10</issue>
                <fpage>1097</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">25127457</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.farrer.2005.738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strain</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maraganore</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 mutations in Parkinson disease.</article-title>
                <source>Neurology</source>
                <year>2005</year>
                <volume>65</volume>
                <fpage>738</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">16157908</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.farrer.2007.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e4;chsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haugarvoll</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2007</year>
                <volume>13</volume>
                <fpage>89</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17222580</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.friedman.2012.7585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachenmayer</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulose</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holstein</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <article-title>Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of &#x003b1;-synuclein and LRRK2 in the brain.</article-title>
                <source>J Neurosci.</source>
                <year>2012</year>
                <volume>32</volume>
                <fpage>7585</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">22649237</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.funayama.2002.296">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Funayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obata</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.</article-title>
                <source>Ann Neurol</source>
                <year>2002</year>
                <volume>51</volume>
                <fpage>296</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">11891824</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.funayama.2005.918">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Funayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawashima</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obata</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.</article-title>
                <source>Ann Neurol</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>918</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">15880653</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gaig.2006.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaig</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ezquerra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valldeoriola</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolosa</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.</article-title>
                <source>Arch Neurol</source>
                <year>2006</year>
                <volume>63</volume>
                <fpage>377</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16533964</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.giasson.2006.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giasson</surname>
                    <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Covy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonini</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurtig</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trojanowski</surname>
                    <given-names>JQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deerlin</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <article-title>Biochemical and pathological characterization of Lrrk2.</article-title>
                <source>Ann Neurol</source>
                <year>2006</year>
                <volume>59</volume>
                <fpage>315</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">16437584</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gilks.2005.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gilks</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abou-Sleiman</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gandhi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinn</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healy</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holton</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revesz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                </person-group>
                <article-title>A common LRRK2 mutation in idiopathic Parkinson's disease.</article-title>
                <source>Lancet</source>
                <year>2005</year>
                <volume>365</volume>
                <fpage>415</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15680457</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gloeckner.2006.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloeckner</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinkl</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schumacher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Neill</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolch</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prokisch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueffing</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.</article-title>
                <source>Hum Mol Genet</source>
                <year>2006</year>
                <volume>15</volume>
                <fpage>223</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">16321986</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.goetz.1982.351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goetz</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klawans</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Drug holiday in the management of Parkinson disease.</article-title>
                <source>Clin Neuropharmacol.</source>
                <year>1982</year>
                <volume>5</volume>
                <issue>4</issue>
                <fpage>351</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">6760963</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.goldwurm.2005.e65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Fonzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohe</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canesi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tesei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecchinelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meucci</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacilotto</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sironi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabrizio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanacore</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalla Libera</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stocchi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diroma</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamberti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampaio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meco</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbosa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertoli-Avella</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.</article-title>
                <source>J Med Genet</source>
                <year>2005</year>
                <volume>42</volume>
                <fpage>e65</fpage>
                <pub-id pub-id-type="pmid">16272257</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.goldwurm.2006.410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Fonzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Gaspari</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Doeselaar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tesei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canesi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecchinelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meucci</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacilotto</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cilia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaias</surname>
                    <given-names>IU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sironi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 G2019S mutation and Parkinson's disease: A clinical, neuropsychological and neuropsychiatric study in a large Italian sample.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2006</year>
                <volume>12</volume>
                <fpage>410</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16750929</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.goldwurm.2007.1141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tesei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miceli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sironi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clementi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease.</article-title>
                <source>Neurology</source>
                <year>2007</year>
                <volume>68</volume>
                <fpage>1141</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">17215492</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gomezesteban.2008.857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-Esteban</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lezcano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zarranz</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilbao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambarri</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garibi</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene.</article-title>
                <source>Neurosurgery</source>
                <year>2008</year>
                <volume>62</volume>
                <fpage>857</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">18496192</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gonzalezfernandez.2007.509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Fern&#x000e1;ndez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lezcano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-Esteban</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-Busto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velasco</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez-Alvarez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez-Mart&#x000ed;nez</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciordia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zarranz</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Pancorbo</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <article-title>Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2007</year>
                <volume>13</volume>
                <fpage>509</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">17540608</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gomezsuaga.2012.692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-Suaga</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilfiker</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 as a modulator of lysosomal calcium homeostasis with downstream effects on autophagy.</article-title>
                <source>Autophagy.</source>
                <year>2012</year>
                <volume>8</volume>
                <fpage>692</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">22441017</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gosal.2005.349">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gosal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irvine</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mark Gibson</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PD.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2005</year>
                <volume>11</volume>
                <fpage>349</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16102999</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.gotthardt.2008.2352">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gotthardt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weyand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kortholt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Haastert</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittinghofer</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase.</article-title>
                <source>EMBO J.</source>
                <year>2008</year>
                <volume>27</volume>
                <fpage>2352</fpage>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.greggio.2006.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greggio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kingsbury</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandopadhyay</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaganovich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Brug</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beilina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blackinton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kesavapany</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cookson</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.</article-title>
                <source>Neurobiol Dis</source>
                <year>2006</year>
                <volume>23</volume>
                <fpage>329</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">16750377</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.greggio.2008.16906">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greggio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambrano</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaganovich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beilina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taymans</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dani&#x000eb;ls</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syed</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baekelandt</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cookson</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.</article-title>
                <source>J Biol Chem</source>
                <year>2008</year>
                <volume>283</volume>
                <fpage>16906</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">18397888</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.guo.2007.3658">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gandhi</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson-Delfosse</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <article-title>The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.</article-title>
                <source>Exp Cell Res</source>
                <year>2007</year>
                <volume>313</volume>
                <fpage>3658</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">17706965</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.haugarvoll.2008.1456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haugarvoll</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuytemans</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaig</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolosa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guidi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riboldazzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benecke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theuns</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cras</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Deyn</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelborghs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pickut</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroud</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samii</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <article-title>Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.</article-title>
                <source>Neurology</source>
                <year>2008</year>
                <volume>70</volume>
                <fpage>1456</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18337586</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.healy.2008.583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Healy</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Sullivan</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolosa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marras</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berciano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapira</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                </person-group>
                <article-title>International LRRK2 Consortium. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.</article-title>
                <source>Lancet Neurol</source>
                <year>2008</year>
                <volume>7</volume>
                <fpage>583</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">18539534</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.hernandez.2005.453">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paisan-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McInerney-Leo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer-Lindenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berman</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nussbaum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.</article-title>
                <source>Ann Neurol</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>453</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15732108</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.herzig.2011.4209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herzig</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolly</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persohn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theil</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweizer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hafner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stemmelen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troxler</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmid</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnell</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muelle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grevot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolognani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stirn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhn</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaupmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Putten</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rovelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimshek</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.</article-title>
                <source>Hum Mol Genet</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>4209</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">21828077</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.hentati.2014.568">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trinh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nosova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>JO</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.</article-title>
                <source>Neurology</source>
                <year>2014</year>
                <volume>83</volume>
                <fpage>568</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25008396</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.higashi.2007.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Higashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trinkaus</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faull</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waldvogel</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emson</surname>
                    <given-names>PC</given-names>
                  </name>
                </person-group>
                <article-title>Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain.</article-title>
                <source>Brain Res</source>
                <year>2007</year>
                <volume>1155</volume>
                <fpage>208</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">17512502</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.holloway.2004.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holloway</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frank</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Review: anticholinergic drugs improve motor function and disability in Parkinson disease.</article-title>
                <source>ACP J Club.</source>
                <year>2004</year>
                <volume>140</volume>
                <fpage>15</fpage>
                <pub-id pub-id-type="pmid">14711286</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.holloway.2004.1044">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holloway</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoulson</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kieburtz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marek</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDermott</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seibyl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamp</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welsh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinaman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pahwa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barclay</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubble</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeWitt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyasaki</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchowersky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammerstad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Standaert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wooten</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Factor</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankovic</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atassi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurlan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panisset</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodnitzky</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shults</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petsinger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biglan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borchert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montgomery</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weeks</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeAngelis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sime</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pantella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrigan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fussell</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dillon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander-Brown</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rainey</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tennis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rost-Ruffner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brocht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daigneault</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgeman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <publisher-name>Parkinson Study Group.</publisher-name>
                <article-title>Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.</article-title>
                <source>Arch Neurol.</source>
                <year>2004</year>
                <volume>61</volume>
                <fpage>1044</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">15262734</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.hristova.2000.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hristova</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koller</surname>
                    <given-names>WC</given-names>
                  </name>
                </person-group>
                <article-title>Early Parkinson's disease: what is the best approach to treatment.</article-title>
                <source>Drugs Aging</source>
                <year>2000</year>
                <volume>17</volume>
                <fpage>165</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11043817</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.hulihan.2008.591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishihara-Paul</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elango</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prinjha</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upmanyu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kefi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zouari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sassi</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahmed</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Euch-Fayeche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.</article-title>
                <source>Lancet Neurol</source>
                <year>2008</year>
                <volume>7</volume>
                <fpage>591</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18539535</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.iaccarino.2007.1319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iaccarino</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crosio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vitale</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanna</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr&#x000ec;</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Apoptotic mechanisms in mutant LRRK2-mediated cell death.</article-title>
                <source>Hum Mol Genet</source>
                <year>2007</year>
                <volume>16</volume>
                <fpage>1319</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">17409193</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.imai.2008.2432">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gehrke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>HQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oota</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.</article-title>
                <source>Embo J</source>
                <year>2008</year>
                <volume>27</volume>
                <fpage>2432</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">18701920</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.infante.2006.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Infante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combarros</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mateo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontalba</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oterino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polo</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berciano</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.</article-title>
                <source>Neurosci Lett</source>
                <year>2006</year>
                <volume>395</volume>
                <fpage>224</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16298482</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.internationalparkinso.2011.641">
              <element-citation publication-type="journal">
                <publisher-name>International Parkinson Disease Genomics Consortium</publisher-name>
                <article-title>Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.</article-title>
                <source>Lancet.</source>
                <year>2011</year>
                <volume>377</volume>
                <fpage>641</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21292315</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.ishihara.2006.1250">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishihara</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tazir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroud</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.</article-title>
                <source>Arch Neurol</source>
                <year>2006</year>
                <volume>63</volume>
                <fpage>1250</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16966502</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.ito.2007.1380">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujino</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichijo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwatsubo</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease.</article-title>
                <source>Biochemistry</source>
                <year>2007</year>
                <volume>46</volume>
                <fpage>1380</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17260967</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.jaleel.2007.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaleel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillardon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knebel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alessi</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.</article-title>
                <source>Biochem J</source>
                <year>2007</year>
                <volume>405</volume>
                <fpage>307</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">17447891</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.jenner.2008.S585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jenner</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Preventing and controlling dyskinesia in Parkinson&#x02019;s disease&#x02014;a view of current knowledge and future opportunities.</article-title>
                <source>Mov Disord</source>
                <year>2008</year>
                <volume>23</volume>
                <supplement>Suppl 3</supplement>
                <fpage>S585</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">18781676</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.kachergus.2005.672">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nutt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maraganore</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czyzewski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Styczynska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.</article-title>
                <source>Am J Hum Genet</source>
                <year>2005</year>
                <volume>76</volume>
                <fpage>672</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15726496</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.kay.2005.1077">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.</article-title>
                <source>Mov Disord</source>
                <year>2005</year>
                <volume>20</volume>
                <fpage>1077</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16001413</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.kay.2006.519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Factor</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nutt</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samii</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.</article-title>
                <source>Mov Disord</source>
                <year>2006</year>
                <volume>21</volume>
                <fpage>519</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16250030</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.khan.2005.2786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavese</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abou-Sleiman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holton</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Healy</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilks</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganguly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbons</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gandhi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaughan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eunson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katzenschlager</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gayton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lennox</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revesz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinn</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.</article-title>
                <source>Brain</source>
                <year>2005</year>
                <volume>128</volume>
                <fpage>2786</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">16272164</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lang.1998a.1044">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lozano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson's disease. First of two parts.</article-title>
                <source>N Engl J Med</source>
                <year>1998a</year>
                <volume>339</volume>
                <fpage>1044</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">9761807</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lang.1998b.1130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lozano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson's disease. Second of two parts.</article-title>
                <source>N Engl J Med</source>
                <year>1998b</year>
                <volume>339</volume>
                <fpage>1130</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">9770561</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.langston.2006.591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Langston</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>The Parkinson's complex: parkinsonism is just the tip of the iceberg.</article-title>
                <source>Ann Neurol</source>
                <year>2006</year>
                <volume>59</volume>
                <fpage>591</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16566021</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.latourelle.2008.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Latourelle</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lew</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchowersky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golbe</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mark</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Growdon</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wooten</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racette</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlmutter</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shill</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldwurm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pezzoli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saint-Hilaire</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendricks</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagle</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilk</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massood</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huskey</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laramie</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeStefano</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litvan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nance</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drasby</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burn</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pramstaller</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-hinti</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roxburgh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slevin</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cambi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gusella</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.</article-title>
                <source>BMC Med</source>
                <year>2008</year>
                <volume>6</volume>
                <fpage>32</fpage>
                <pub-id pub-id-type="pmid">18986508</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lee.2010a.16959">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction.</article-title>
                <source>J Neurosci.</source>
                <year>2010a</year>
                <volume>30</volume>
                <fpage>16959</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">21159966</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lee.2010b.998">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>VanKampen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrucelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>YI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maguire-Zeiss</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowers</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federoff</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <article-title>Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.</article-title>
                <source>Nat Med.</source>
                <year>2010b</year>
                <volume>16</volume>
                <fpage>998</fpage>
                <lpage>1000</lpage>
                <pub-id pub-id-type="pmid">20729864</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lesage.2006.422">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tazir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leutenegger</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollak</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.</article-title>
                <source>N Engl J Med</source>
                <year>2006</year>
                <volume>354</volume>
                <fpage>422</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16436781</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lesage.2005.784">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ibanez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollak</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tazir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leutenegger</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>G2019S LRRK2 mutation in French and North African families with Parkinson's disease.</article-title>
                <source>Ann Neurol</source>
                <year>2005</year>
                <volume>58</volume>
                <fpage>784</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16240353</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lewis.2007.668">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greggio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beilina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cookson</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>The R1441C mutation of LRRK2 disrupts GTP hydrolysis.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <year>2007</year>
                <volume>357</volume>
                <fpage>668</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">17442267</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.li.2007.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olanow</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>XY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <article-title>Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.</article-title>
                <source>J Neurochem</source>
                <year>2007</year>
                <volume>103</volume>
                <fpage>238</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">17623048</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.li.2009.826">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oo</surname>
                    <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson-Lewis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geghman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bogdanov</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Przedborski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beal</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.</article-title>
                <source>Nat Neurosci</source>
                <year>2009</year>
                <volume>12</volume>
                <fpage>826</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19503083</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lill.2012.e1002548">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lill</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roehr</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McQueen</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kavvoura</surname>
                    <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagade</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schjeide</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schjeide</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meissner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zauft</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilling</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beecham</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biernacka</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeStefano</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Do</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Factor</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroud</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamza</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heutink</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill-Burns</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latourelle</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maraganore</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nalls</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pankratz</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satake</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tung</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.</article-title>
                <source>PLoS Genet.</source>
                <year>2012</year>
                <volume>8</volume>
                <fpage>e1002548</fpage>
                <pub-id pub-id-type="pmid">22438815</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lu.2005.521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu-Chou</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonzo</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weng</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohe</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2005</year>
                <volume>11</volume>
                <fpage>521</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">16256409</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.lu.2008.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu-Chou</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Doeselaar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Fonzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weng</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.</article-title>
                <source>Neurogenetics</source>
                <year>2008</year>
                <volume>9</volume>
                <fpage>271</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18716801</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.luzontoro.2007.2031">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luz&#x000f3;n-Toro</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio de la Torre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delgado</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Tur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilfiker</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.</article-title>
                <source>Hum Mol Genet</source>
                <year>2007</year>
                <volume>16</volume>
                <fpage>2031</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17584768</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.macleod.2006.587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacLeod</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammond</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leete</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abeliovich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>The familial Parkinsonism gene LRRK2 regulates neurite process morphology.</article-title>
                <source>Neuron</source>
                <year>2006</year>
                <volume>52</volume>
                <fpage>587</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">17114044</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.marjamalyons.2001.24">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marjama-Lyons</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koller</surname>
                    <given-names>WC</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson's disease: Update in diagnosis and symptom management.</article-title>
                <source>Geriatrics</source>
                <year>2001</year>
                <volume>56</volume>
                <fpage>24</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11505857</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.mata.2009.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosentino</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marca</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzetti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortega</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raggio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aljanati</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buz&#x000f3;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yearout</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dieguez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>370</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18980856</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.mata.2005a.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobb</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahoz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Lrrk2 pathogenic substitutions in Parkinson's disease.</article-title>
                <source>Neurogenetics</source>
                <year>2005a</year>
                <volume>6</volume>
                <fpage>171</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16172858</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.mata.2006a.391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huerta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribacoba</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moris</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazquez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guisasola</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvador</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 mutations are a common cause of Parkinson's disease in Spain.</article-title>
                <source>Eur J Neurol</source>
                <year>2006a</year>
                <volume>13</volume>
                <fpage>391</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16643318</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.mata.2005b.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huerta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahoz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazquez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guisasola</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvador</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribacoba</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 R1441G in Spanish patients with Parkinson's disease.</article-title>
                <source>Neurosci Lett</source>
                <year>2005b</year>
                <volume>382</volume>
                <fpage>309</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">15925109</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.mata.2006b.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wedemeyer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallo</surname>
                    <given-names>KA</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 in Parkinson's disease: protein domains and functional insights.</article-title>
                <source>Trends Neurosci</source>
                <year>2006b</year>
                <volume>29</volume>
                <fpage>286</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16616379</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.miklossy.2006.953">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miklossy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klegeris</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGeer</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGeer</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 expression in normal and pathologic human brain and in human cell lines.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <year>2006</year>
                <volume>65</volume>
                <fpage>953</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">17021400</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.mirelman.2013.1683">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirelman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heman</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasinovsky</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thaler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurevich</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marder</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bar-Shira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orr-Urtreger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giladi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausdorff</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 Ashkenazi Jewish Consortium. Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation.</article-title>
                <source>Mov Disord.</source>
                <year>2013</year>
                <volume>28</volume>
                <issue>12</issue>
                <fpage>1683</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">24123150</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.munhoz.2009.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Munhoz</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teive</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francisco</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Unilateral pallidotomy in a patient with parkinsonism and G2019S LRRK2 mutation.</article-title>
                <source>Mov Disord</source>
                <year>2009</year>
                <volume>24</volume>
                <fpage>791</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19012346</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.nandhagopal.2008.1790">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nandhagopal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenzie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCormick</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sossi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruth</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strongosky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study.</article-title>
                <source>Neurology</source>
                <year>2008</year>
                <volume>71</volume>
                <fpage>1790</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19029519</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.nichols.2005.410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pankratz</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paisan-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halter</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michaels</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolph</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shults</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroud</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.</article-title>
                <source>Lancet</source>
                <year>2005</year>
                <volume>365</volume>
                <fpage>410</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15680455</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.olanow.2004.72">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olanow</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stocchi</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications?</article-title>
                <source>Neurology</source>
                <year>2004</year>
                <volume>62</volume>
                <supplement>Suppl 1</supplement>
                <fpage>72</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">14718700</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.ozelius.2006.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senthil</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deligtisch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagliati</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunt</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henick</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hailpern</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soto-Valencia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.</article-title>
                <source>N Engl J Med</source>
                <year>2006</year>
                <volume>354</volume>
                <fpage>424</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16436782</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.paisanruiz.2004.595">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paisan-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilks</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Brug</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aparicio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gil</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrera</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Silva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti-Masso</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Tur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <article-title>Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.</article-title>
                <source>Neuron</source>
                <year>2004</year>
                <volume>44</volume>
                <fpage>595</fpage>
                <lpage>600</lpage>
                <pub-id pub-id-type="pmid">15541308</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.paisanruiz.2005.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paisan-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saenz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez Gil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti-Masso</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Tur</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Familial Parkinson's disease: clinical and genetic analysis of four Basque families.</article-title>
                <source>Ann Neurol</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>365</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">15732106</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.perry.2008.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babar</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siedlak</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwatsubo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <article-title>Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies.</article-title>
                <source>Neurodegener Dis</source>
                <year>2008</year>
                <volume>5</volume>
                <fpage>222</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18322396</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.piccoli.2011.2225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Condliffe</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giesert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boldt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Astis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meixner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarioglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogt-Weisenhorn</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wurst</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloeckner</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matteoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sala</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueffing</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.</article-title>
                <source>J Neurosci.</source>
                <year>2011</year>
                <volume>31</volume>
                <fpage>2225</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">21307259</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.plowey.2008.1048">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plowey</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherra</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>CT</given-names>
                  </name>
                </person-group>
                <article-title>Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.</article-title>
                <source>J Neurochem.</source>
                <year>2008</year>
                <volume>105</volume>
                <fpage>1048</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">18182054</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.rajput.2006.1506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dachsel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobb</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Parkinsonism, Lrrk2 G2019S, and tau neuropathology.</article-title>
                <source>Neurology</source>
                <year>2006</year>
                <volume>67</volume>
                <fpage>1506</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17060589</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.ross.2009.466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spanaki</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haugarvoll</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latsoudis</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plaitakis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampaio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>466</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18952485</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.ross.2011.898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soto-Ortolaza</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heckman</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abahuni</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacon</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardien</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brighina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chartier-Harlin</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dardiotis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diehl</surname>
                    <given-names>NN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elbaz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrarese</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferraris</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiske</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadjigeorgiou</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannidis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jasinska-Myga</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeon</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyratzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maraganore</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellick</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilsson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opala</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puschmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quattrone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silburn</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohn</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theuns</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomiyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valente</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Loo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vassilatis</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilari&#x000f1;o-G&#x000fc;ell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirdefeldt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <publisher-name>Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium</publisher-name>
                <article-title>Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.</article-title>
                <source>Lancet Neurol.</source>
                <year>2011</year>
                <volume>10</volume>
                <fpage>898</fpage>
                <lpage>908</lpage>
                <pub-id pub-id-type="pmid">21885347</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.ross.2006.388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittle</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapetropoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mash</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litvan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>Lrrk2 and Lewy body disease.</article-title>
                <source>Ann Neurol</source>
                <year>2006</year>
                <volume>59</volume>
                <fpage>388</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16437559</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.ross.2008.88">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>YR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soto</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Chen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.</article-title>
                <source>Ann Neurol</source>
                <year>2008</year>
                <volume>64</volume>
                <fpage>88</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">18412265</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.santosreboucas.2008.471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Santos-Rebou&#x000e7;as</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdalla</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldi</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corr&#x000ea;a</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gon&#x000e7;alves</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunha</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borges</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laks</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pimentel</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <article-title>Co-occurrence of sporadic parkinsonism and late-onset Alzheimer's disease in a Brazilian male with the LRRK2 p.G2019S mutation.</article-title>
                <source>Genet Test</source>
                <year>2008</year>
                <volume>12</volume>
                <fpage>471</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19072560</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.saunderspullman.2006.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senthil</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costan-Toth</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Derby</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verghese</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <article-title>Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia.</article-title>
                <source>Neurosci Lett</source>
                <year>2006</year>
                <volume>402</volume>
                <fpage>92</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16632201</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.schupbach.2007.119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sch&#x000fc;pbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anheim</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czernecki</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaici</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worbe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charles</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welter</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollak</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.</article-title>
                <source>Mov Disord</source>
                <year>2007</year>
                <volume>22</volume>
                <fpage>119</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">17080443</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.simonsanchez.2006.1954">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sim&#x000f3;n-S&#x000e1;nchez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;-Mass&#x000f3;</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez-Mut</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pais&#x000e1;n-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Gil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Mart&#x000ed;nez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Tur</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques.</article-title>
                <source>Mov Disord</source>
                <year>2006</year>
                <volume>21</volume>
                <fpage>1954</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16991141</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.smith.2006.1231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pei</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Kinase activity of mutant LRRK2 mediates neuronal toxicity.</article-title>
                <source>Nat Neurosci</source>
                <year>2006</year>
                <volume>9</volume>
                <fpage>1231</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16980962</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.smith.2005.18676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pei</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <year>2005</year>
                <volume>102</volume>
                <fpage>18676</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">16352719</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.tan.2010.561">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teo</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angeles</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>XY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>XL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prakash</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Au</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankovic</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgunder</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.</article-title>
                <source>Hum Mutat.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>561</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20186690</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.tan.2008.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>HQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yih</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavanni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prakash</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fook-Chong</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 R1628P increases risk of Parkinson's disease: replication evidence.</article-title>
                <source>Hum Genet</source>
                <year>2008</year>
                <volume>124</volume>
                <fpage>287</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18781329</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.tan.2006.857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skipper</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Fonzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fook-Chong</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chua</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavanni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolatkar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonifati</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.</article-title>
                <source>Hum Genet</source>
                <year>2006</year>
                <volume>120</volume>
                <fpage>857</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">17019612</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.taylor.2006.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?</article-title>
                <source>Trends Mol Med</source>
                <year>2006</year>
                <volume>12</volume>
                <fpage>76</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16406842</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.toft.2005.1229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toft</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mata</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 mutations and Parkinsonism.</article-title>
                <source>Lancet</source>
                <year>2005</year>
                <volume>365</volume>
                <fpage>1229</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15811454</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.tomiyama.2006.1102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomiyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inzelberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Djaldetti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melamed</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gouider-Khouja</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imamichi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizoguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyajima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obata</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.</article-title>
                <source>Mov Disord</source>
                <year>2006</year>
                <volume>21</volume>
                <fpage>1102</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16622854</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.tong.2012.2">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giaime</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichimura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Si</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonventre</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway.</article-title>
                <source>Mol Neurodegener.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>2</fpage>
                <pub-id pub-id-type="pmid">22230652</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.trinh.2014a.1125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Trinh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duda</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morley</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarino-Guell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szu Tu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gustavsson</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sassi</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zouari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farhat</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>A comparative study of Parkinson&#x02019;s disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.</article-title>
                <source>Neurobiol Aging</source>
                <year>2014a</year>
                <volume>35</volume>
                <fpage>1125</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">24355527</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.trinh.2014b.1">
              <mixed-citation publication-type="book">Trinh J, Guella I, Farrer M (2014b) Disease penetrance of late-onset parkinsonism: a meta-analysis. JAMA Neurol. Epub ahead of print</mixed-citation>
            </ref>
            <ref id="lrrk2.REF.ujiie.2012.819">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ujiie</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yagishita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>LRRK2 I2020T mutation is associated with tau pathology.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2012</year>
                <volume>18</volume>
                <fpage>819</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">22525366</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.vanegmond.2008.30412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Egmond</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kortholt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosgraaf</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosgraaf</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keizer-Gunnink</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Haastert</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <article-title>Intramolecular Activation Mechanism of the Dictyostelium LRRK2 Homolog Roco Protein GbpC.</article-title>
                <source>J Biol Chem</source>
                <year>2008</year>
                <volume>283</volume>
                <fpage>30412</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">18703517</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.west.2005.16842">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugayenko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <article-title>Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <year>2005</year>
                <volume>102</volume>
                <fpage>16842</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16269541</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.williamsgray.2006.665">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams-Gray</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goris</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foltynie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maranian</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compston</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawcer</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <year>2006</year>
                <volume>77</volume>
                <fpage>665</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16614029</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.wszolek.2004.1619">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McComb</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strongosky</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller-Myhsok</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.</article-title>
                <source>Neurology</source>
                <year>2004</year>
                <volume>62</volume>
                <fpage>1619</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15136696</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.zabetian.2006.697">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zabetian</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ujike</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaji</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leis</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yearout</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samii</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease.</article-title>
                <source>Neurology</source>
                <year>2006</year>
                <volume>67</volume>
                <fpage>697</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16728648</pub-id>
              </element-citation>
            </ref>
            <ref id="lrrk2.REF.zimprich.2004.601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leitner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kachergus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitti</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patenge</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbajal</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieregge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asmus</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller-Myhsok</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.</article-title>
                <source>Neuron</source>
                <year>2004</year>
                <volume>44</volume>
                <fpage>601</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15541309</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="lrrk2.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="lrrk2.Author_Notes">
          <title>Author Notes</title>
          <p>Dr. Ross currently directs the Division of the Neurogenetics at Mayo Clinic Jacksonville, and the Genetic Core of a Morris K Udall Center of Excellence for the Genetics of Parkinson's disease. Current research is supported through the National Institutes of Health (NINDS), the Michael J Fox Foundation, and the Mayo Foundation.</p>
          <p>Dr. Farrer and colleagues' research interests are focused on the genetic analysis of parkinsonism and related movement and memory disorders. Research interests include statistical and molecular genetics, functional genomics, and applied neurobiology, including the creation of animal models of parkinsonism based on molecular etiology. Dr. Farrer reports (a) International Publication Number WO 2006/045392 A2; (b) International Publication Number WO 2006/068492 A1; (c) US Patent Number 7,544,786; and (d) Norwegian patent 323175, related to LRRK2. Dr Farrer reports salary and royalty payment from the Pharmaceutical Industry for sponsored research on Lrrk2 biology and mouse model characterization. As of August 2008, Mayo and Dr. Farrer have received royalties from the licensing of these technologies of greater than $10,000, the US federal threshold for significant financial interest.</p>
        </sec>
        <sec id="lrrk2.Acknowledgments">
          <title>Acknowledgments</title>
          <list list-type="bullet">
            <list-item>
              <p>Morris K Udall Center of Excellence for the Genetics of Parkinson's disease</p>
            </list-item>
            <list-item>
              <p>Current research supported through the National Institutes of Health (NINDS, NIEHS and NIA), the Michael J Fox Foundation, and the Mayo Foundation</p>
            </list-item>
            <list-item>
              <p>All the individuals involved in our research including the many scientists, clinicians, and especially the patients and their families</p>
            </list-item>
          </list>
        </sec>
        <sec id="lrrk2.Author_History">
          <title>Author History</title>
          <p>Matthew Farrer, PhD (2006-present)Ilaria Guella, PhD (2014-present)Owen A Ross, PhD (2006-present)Jeremy T Stone, BSc; Mayo Clinic (2006-2010)Joanne Trinh, BSc (2014-present)</p>
        </sec>
        <sec id="lrrk2.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 December 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>13 September 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 April 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>2 November 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>6 July 2006 (mf) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="lrrk2.1.11" sec-type="figs-and-tables">
        <title/>
        <fig id="lrrk2.F1" position="float" orientation="portrait">
          <label>Figure 1.</label>
          <caption>
            <p>Schematic representation of the 144-kb <italic toggle="yes">LRRK2</italic> loci on chromosome 12q12. The estimated start of the Lrrk2 domain structure is indicated by the residue number below the exonic-intronic (Ex1-Ex51) and domain scheme (690). Domains:ANK = ankyrin repeat region LRR = leucine-rich repeat Roc = Ras of complex; GTPase COR = C terminal of Ras MAPKKK = MAPK kinase kinase WD40</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lrrk2Fig1" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
